Unfair business ways: CCI Fine on Medical Device maker Esaote

Published On 2018-09-28 04:50 GMT   |   Update On 2018-09-28 04:50 GMT
New Delhi: The Competition Commission has penalised Italy's Esaote SpA and its group entity Esaote Asia Pacific Diagnostic for unfair business practices in the supply of certain MRI machines, according to an order.

Besides imposing a fine of Rs 9.33 lakh on the two entities, the watchdog has directed them to "cease and desist" from indulging in anti-competitive practices.

The Competition Commission of India (CCI) has found that the two entities abused their dominant position in supplying dedicated standing/tilting MRI (Magnetic Resonance Imaging) machines.

The order has been passed on a complaint filed by House of Diagnostics LLP, which is into medical diagnostics and diagnostic imaging services.

It was alleged that Esaote charged a huge sum of money for supplying spare parts and refused to perform its obligations under the contract.

Among others, the regulator found that Esaote acted unfairly and thereby abused its dominant position by refusing to provide head coils with the machines to the informant, an official release said Thursday.

"The CCI also found Esaote to have demanded arbitrary charges in derogation of its contractual obligations for comprehensive maintenance contract in respect of G-Scan MRI machines," it added.

The fine amount of Rs 9.33 lakh translates to 10 per cent of the average relevant turnover of the preceding three financial years from the sale of G-Scan MRI machines in India only.

The majority order was passed by CCI members Augustine Peter and U C Nahta, while Chairperson Sudhir Mittal gave a dissent note.
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News